Evaluate the Frequency of Fatigue After Cerebral Infarction

Fatigue After Stroke

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03288090

Acronym

Fatigue AVC

Enrollment

126

Registered

2017-09-19

Start date

2017-09-11

Completion date

2018-11-22

Last updated

2026-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Symptomatic Cerebral Infarction

Brief summary

Cerebral infarction is a type of stroke that can lead to sometimes disabling sequelae. Among these sequelae, fatigue is frequently reported by patients. It is therefore important for doctors to understand why patients suffer from fatigue after cerebral infarction and to determine whether treatments given for the cerebral infarction may have an impact on this fatigue. The aim of this research was to study the frequency of fatigue after cerebral infarction, the associated factors, in particular the impact of treatments administered in the acute phase.

Interventions

OTHERFSS: Fatigue Severity Scale

Fatigue scale with 9 items rated from 1 to 7, assessing physical fatigue, fatigue in the psychosocial environment and fatigue in general (3 items in each category).

OTHERNeuropsychological evaluation battery

A standardized French neuropsychological battery for the cognitive evaluation of stroke patients.

OTHEROther functional scores

Rankin Score, Instrumental Activities of Daily Living (IADL) Score, Rivermead Mobility Index (RMI) scale, Hospital Anxiety Depression scale (HAD) scale for depression / anxiety, Stroke Specific Quality of Life scale for quality of life, Quality Index of Pittsburgh Sleep (PSQI), Vertical Analog Visual Scale for Pain and Vertical Digital Visual Scale

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients presenting recent symptomatic cerebral infarction (\< 1 week) defined according to World Health Organization (WHO) criteria and hospitalised at the Stroke Unit in Dijon University. * Patients aged 18 years or older. * Patients who have been informed about the study, or their person of trust for patients unable to express their consent.

Exclusion criteria

* Patients (or their person of trust) who refuse to participate in the study. * Subjects in custody. * Patients presenting prior co-morbidity as a cause of significant fatigue in the opinion of the investigator * Patients with dementia or aphasia before the stroke * Patients (or their person of trust) who may be difficult to contact by telephone during the follow-up.

Design outcomes

Primary

Measure	Time frame
Fatigue evaluated using the Fatigue Severity Scale (FSS)	6 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026